Abcl stock price

Abcl stock price Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ...AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.84 -0.01 (-0.17%) At close: 04:00PM EDT. 5.80 -0.04 ( …25malxhd earnings date AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ... At that level, ABCL’s share price would be -295.48% below current price. To see how AbCellera Biologics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ABCL stock’s performance was 7.11% in the latest trading, and -10.38% in the past year, while AbbVie Inc. (ABBV) has traded -1.64% on the day ...AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 5.84 -0.01 (-0.17%) At close: 04:00PM EDT. 5.80 -0.04 (-0.68%) After hours: 07:58PM EDT.May 24, 2023 · At that level, ABCL’s share price would be -295.48% below current price. To see how AbCellera Biologics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ABCL stock’s performance was 7.11% in the latest trading, and -10.38% in the past year, while AbbVie Inc. (ABBV) has traded -1.64% on the day ... What's Happening With CVAC Stock Today? CureVac BV (CVAC) stock is trading at $9.78 as of 1:35 PM on Monday, May 22, a rise of $0.72, or 7.95% from the previous closing price of $9.06. The stock has traded between $9.27 and $9.78 so far today. Volume today is 452,890 compared to average volume of 483,375. More About CureVac BV outback santa fe Oct 21, 2022 · The mean of analysts' price targets for AbCellera Biologics Inc. (ABCL) points to a 137.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... AbCellera Biologics Inc. - Hold. Zacks' proprietary data indicates that AbCellera Biologics Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the ABCL shares ...Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you …Get Abcellera Biologics Inc (ABCL.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsView the latest AbCellera Biologics Inc. (ABCL) stock price, news, historical charts, analyst ratings and financial information from WSJ.AbCellera Biologics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ABCL updated stock price target summary. ... Stock Price Target ABCL. High $ 38.00: Median $ 28.00 ... DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... pick a poke AbCellera Biologics Inc. Common Shares (ABCL) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Mar 22, 2023 · Read the latest news AbCellera Biologics Inc. (NASDAQ: ABCL) What's Happening With ABCL Stock Today? AbCellera Biologics Inc (ABCL) stock is trading at $6.55 as of 1:31 PM on Monday, May 22, a gain of $0.71, or 12.16% from the previous closing price of $5.84. The stock has traded between $5.76 and $6.68 so far today. Volume today is above average.DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...AbCellera Biologics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ABCL updated stock price target summary. ... Stock Price Target ABCL. High …DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... annaly stock price ABCL Stock Price | AbCellera Biologics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch. Dow. 33,408.31. -127.60. -0.38%. S&P 500. 4,187.56. -10.49.What's Happening With ABCL Stock Today? AbCellera Biologics Inc (ABCL) stock is trading at $6.55 as of 1:31 PM on Monday, May 22, a gain of $0.71, or 12.16% from the previous closing price of $5.84. The stock has traded between $5.76 and $6.68 so far today. Volume today is above average.Find the latest AbCellera Biologics Inc. (ABCL) stock quote, history, news and other vital information to help you with your stock trading and investing. order chinese food online According to 7 analysts, the average rating for ABCL stock is "Strong Buy." The 12-month stock price forecast is $26.5, which is an increase of 265.27% from the latest price. Price TargetLooking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.View the latest AbCellera Biologics Inc. (ABCL) stock price, news, historical charts, analyst ratings and financial information from WSJ.Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis. May 22, 2023 · What's Happening With ABCL Stock Today? AbCellera Biologics Inc (ABCL) stock is trading at $6.55 as of 1:31 PM on Monday, May 22, a gain of $0.71, or 12.16% from the previous closing price of $5.84. The stock has traded between $5.76 and $6.68 so far today. Volume today is above average. Abcellera Biologics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... ABCL Stock Quotes API . ABCL Related ETF s. Symbol %Holdings 3M %Chg; ABCL -16.80% : Abcellera Biologics Inc: IWM : 0.05% -6.27% : Russell 2000 Ishares ETF: IBB : 0.11% +1.64% : cat and rabbitt AbCellera Biologics Stock Earnings. The value each ABCL share was expected to gain vs. the value that each ABCL share actually gained. AbCellera Biologics ( ABCL) reported Q1 2023 earnings per share (EPS) of -$0.14, missing estimates of -$0.13 by 11.52%. In the same quarter last year, AbCellera Biologics 's earnings per share (EPS) was $0.59.A quick review shows that ABCL’s price is currently 14.31% off the SMA20 and 2.57% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.51, …DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...The mean of analysts' price targets for AbCellera Biologics Inc. (ABCL) points to a 137.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ABCL stock stock is $26.5, which predicts an increase of 352.99%. The lowest target is 18 and the highest is 32. On average, analysts rate ABCL stock stock as a strong buy. outback bluffton stufd AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ...Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis. burger houseFind the latest AbCellera Biologics Inc. (ABCL) stock quote, history, news and other vital information to help you with your stock trading and investing.Get Abcellera Biologics Inc (ABCL.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsLooking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.Stock analysis for AbCellera Biologics Inc (ABCL:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Traders who pay close attention to intraday price movement should know that it fluctuated between $20.651 and $21.15. In examining the 52-week price action we see that the stock hit a 52-week high of $29.89 and a 52-week low of $18.62. Over the past month, the stock has lost -14.07% in value. olitoki May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. The project is expected to create hundreds of new high-skilled jobs at AbCellera. AbCellera (Nasdaq: ABCL) today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based medicines and strengthen Canada’s …DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of AbCellera Biologics Inc (Symbol: ABCL) entered into oversold territory, hitting an RSI ...2 days ago · DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... Stock Price Forecast. According to 6 stock analysts, the average 12-month stock price forecast for ABCL stock stock is $26.5, which predicts an increase of 352.99%. The lowest target is 18 and the highest is 32. On average, analysts rate ABCL stock stock as a strong buy.DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... lucca osteria and bar2 days ago · DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis.AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ... take a bao Their ABCL share price forecasts range from $15.00 to $34.00. On average, they predict the company's share price to reach $25.57 in the next year. This suggests a possible upside of 264.3% from the stock's current price. View analysts price targets for ABCL or view top-rated stocks among Wall Street analysts.Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of AbCellera Biologics Inc (Symbol: ABCL) entered into …AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ...At that level, ABCL’s share price would be -295.48% below current price. To see how AbCellera Biologics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ABCL stock’s performance was 7.11% in the latest trading, and -10.38% in the past year, while AbbVie Inc. (ABBV) has traded -1.64% on the day ...Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Discover historical prices for ABCL stock on Yahoo Finance. View daily, weekly or monthly format back to when AbCellera Biologics Inc. stock was issued. Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Discover historical prices for ABCL stock on Yahoo Finance. View daily, weekly or monthly format back to when AbCellera Biologics Inc. stock was issued.Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio.Find real-time ABCL - Abcellera Biologics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Price/Sales: 6.57: Price/Book: 1.36: Competitors. No competitors data available.Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. marketbeat.com - February 22 at 9:57 AM. Berenberg Bank Keeps Their Buy Rating on AbCellera Biologics (ABCL) markets.businessinsider.com - February 22 at 8:24 AM. AbCellera Biologics GAAP EPS of $0.50 misses by $0.09, revenue of $485.42M misses by $32.31M. msn.com - February 21 at 6:46 PM.Traders who pay close attention to intraday price movement should know that it fluctuated between $20.651 and $21.15. In examining the 52-week price action we see that the stock hit a 52-week high of $29.89 and a 52-week low of $18.62. Over the past month, the stock has lost -14.07% in value.Feb 2, 2023 · Given its relevancies, ABCL stock gained 13% of equity value in the trailing year. Still, ABCL surprisingly ranks among the most undervalued biotech stocks to buy. Currently, the market prices ... casita del campo DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. View AbCellera Biologics Inc ABCL investment & stock information. Get the latest AbCellera Biologics Inc ABCL detailed stock quotes, stock data, Real-Time ECN, … kono's waikiki sp500 after hours interest rate hikes 2022May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. View the latest AbCellera Biologics Inc. (ABCL) stock price, news, historical charts, analyst ratings and financial information from WSJ.ABCL Valuation Summary. In comparison to the median Healthcare stock, ABCL's price/sales ratio is 86.27% higher, now standing at 9.5. ABCL's price/earnings …What's Happening with BAX Stock Today Baxter International Inc (BAX) stock is down -0.54% while the S&P 500 is higher by 0.16% as of 1:48 PM on Monday, May 22. BAX is down -$0.23 from the previous closing price of $42.99 on volume of 1,344,967 shares. Over the past year the S&P 500 is up 5.66% while BAX is down -41.72%. on semiconductor stock May 23, 2023 · 8 brokers have issued twelve-month price targets for AbCellera Biologics' stock. Their ABCL share price forecasts range from $15.00 to $34.00. On average, they expect the company's share price to reach $25.57 in the next year. This suggests a possible upside of 337.9% from the stock's current price. A quick review shows that ABCL’s price is currently 14.31% off the SMA20 and 2.57% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.51, and weekly volatility stands at 8.75%. When measured over the past 30 days, the indicator reaches 5.93%. AbCellera Biologics Inc. (NASDAQ:ABCL)’s beta value is currently …Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio.2 days ago · DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... first watch royal oak Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.AbCellera Biologics Inc. - Hold. Zacks' proprietary data indicates that AbCellera Biologics Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the ABCL shares ... peking media May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. AbCellera Biologics Inc. (ABCL) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 5.84 -0.01 (-0.17%) At close: 04:00PM EDT. 5.80 -0.04 (-0.68%) …Get Abcellera Biologics Inc (ABCL.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsWhat's Happening with BAX Stock Today Baxter International Inc (BAX) stock is down -0.54% while the S&P 500 is higher by 0.16% as of 1:48 PM on Monday, May 22. BAX is down -$0.23 from the previous closing price of $42.99 on volume of 1,344,967 shares. Over the past year the S&P 500 is up 5.66% while BAX is down -41.72%. turkish coffee near me zauq halal kitchenAbCellera Biologics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ABCL stock price.See the latest AbCellera Biologics Inc Ordinary Shares stock price (NASDAQ:ABCL), related news, valuation, dividends and more to help you make your … restaurants in selinsgrove pa The mean of analysts' price targets for AbCellera Biologics Inc. (ABCL) points to a 137.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ...May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Data is delayed at least 15 minutes. martins groceries to go Get Abcellera Biologics Inc (ABCL.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsAbCellera Biologics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ABCL updated stock price target summary. ... Stock Price Target ABCL. High $ 38.00: Median $ 28.00 ... Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio.Shares of AbCellera Biologics ( ABCL -4.68%) closed 7.1% higher today following news of a new partnership with Moderna ( MRNA -3.95%), one of the first names to develop an effective COVID-19 vaccine. context logic Feb 2, 2023 · Given its relevancies, ABCL stock gained 13% of equity value in the trailing year. Still, ABCL surprisingly ranks among the most undervalued biotech stocks to buy. Currently, the market prices ... AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ... ABCL's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing. staa stock AbCellera Biologics Inc (ABCL) stock is trading at $6.55 as of 1:31 PM on Monday, May 22, a gain of $0.71, or 12.16% from the previous closing price of $5.84. The stock has traded between $5.76 and $6.68 so far today. Volume today is above average.Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.Get the latest AbCellera Biologics Inc. (ABCL) stock news and headlines to help you in your trading and investing decisions.2 days ago · DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... A high-level overview of AbCellera Biologics Inc. (ABCL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … wallys deli 2 days ago · DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ... Latest ABCL News. View. Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $25.57. Zolmax • about 5 hours ago. AbCellera Biologics Inc. …ABCL's dividend yield, history, payout ratio, proprietary DARS™ rating & much more! Dividend.com: The #1 Source For Dividend Investing.Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio. usoi dividend history May 24 (Reuters) - AbCellera Biologics Inc ABCL.O said on Wednesday it will make a C$701 million ($524.23 million) co-investment with the governments of …May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. rosies new york pizza nettbarView the latest AbCellera Biologics Inc. (ABCL) stock price, news, historical charts, analyst ratings and financial information from WSJ.May 19, 2023 · 70,6%. More Financials. Company. AbCellera Biologics Inc. is a technology company that searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. The Companyâ€™s full-stack, AI-powered antibody discovery platform searches and analyzes the database of ... AbCellera Biologics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ABCL stock price. alwadi mediterranean Get the latest AbCellera Biologics Inc (ABCL) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions ...Finance. The trading price of T Stamp Inc. (NASDAQ:IDAI) closed higher on Tuesday, May 23, closing at $1.88, 29.66% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $1.54 and $2.1947. In examining the 52-week price action we see that the stock hit a 52-week … electric cheetah20 hours ago · Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio. Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio.Discover historical prices for ABCL stock on Yahoo Finance. View daily, weekly or monthly format back to when AbCellera Biologics Inc. stock was issued.Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.AbCellera Biologics Inc. Common Shares (ABCL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. src stock At that level, ABCL’s share price would be -295.48% below current price. To see how AbCellera Biologics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ABCL stock’s performance was 7.11% in the latest trading, and -10.38% in the past year, while AbbVie Inc. (ABBV) has traded -1.64% on the day ...Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio.Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.Mar 22, 2023 · Read the latest news AbCellera Biologics Inc. (NASDAQ: ABCL) Discover historical prices for ABCL stock on Yahoo Finance. View daily, weekly or monthly format back to when AbCellera Biologics Inc. stock was issued.20 hours ago · Indeed, ABCL feels like it may have finally found a hard bottom after falling more than 80% from its IPO price late in 2020. This is a recent addition to my portfolio. eggbred May 22, 2023 · What's Happening with BAX Stock Today Baxter International Inc (BAX) stock is down -0.54% while the S&P 500 is higher by 0.16% as of 1:48 PM on Monday, May 22. BAX is down -$0.23 from the previous closing price of $42.99 on volume of 1,344,967 shares. Over the past year the S&P 500 is up 5.66% while BAX is down -41.72%. ABCL Stock Price | AbCellera Biologics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch. Dow. 33,408.31. -127.60. -0.38%. S&P 500. 4,187.56. -10.49.ABCL Stock Price - AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies thatFind real-time ABCL - Abcellera Biologics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Price/Sales: 6.57: Price/Book: 1.36: Competitors. No competitors data available. According to 7 analysts, the average rating for ABCL stock is "Strong Buy." The 12-month stock price forecast is $26.5, which is an increase of 265.27% from the latest price. Price Target hackett hot wings Feb 2, 2023 · Given its relevancies, ABCL stock gained 13% of equity value in the trailing year. Still, ABCL surprisingly ranks among the most undervalued biotech stocks to buy. Currently, the market prices ... A quick review shows that ABCL’s price is currently 14.31% off the SMA20 and 2.57% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.51, and weekly volatility stands at 8.75%. When measured over the past 30 days, the indicator reaches 5.93%. AbCellera Biologics Inc. (NASDAQ:ABCL)’s beta value is currently …Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis. maggianos italian restaurant Mar 22, 2023 · Read the latest news AbCellera Biologics Inc. (NASDAQ: ABCL) Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.AbCellera Biologics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ABCL stock price. AbCellera Biologics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time ABCL stock price. shawarma on the run Traders who pay close attention to intraday price movement should know that it fluctuated between $20.651 and $21.15. In examining the 52-week price action we see that the stock hit a 52-week high of $29.89 and a 52-week low of $18.62. Over the past month, the stock has lost -14.07% in value.Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis.Find the latest AbCellera Biologics Inc. (ABCL) stock quote, history, news and other vital information to help you with your stock trading and investing. cambio de dolares a pesos colombianos hoyDA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...DA Davidson maintained PacWest Banc with a Neutral and raised the price target from $3 to $8. ... Inc. ABCL gained 11 ... offering of 655,569 shares of common stock at a price of $2.20 per share ...The project is expected to create hundreds of new high-skilled jobs at AbCellera. AbCellera (Nasdaq: ABCL) today announced a CA$701 million co-investment with the Governments of Canada and British Columbia to build new capabilities and infrastructure to develop innovative antibody-based medicines and strengthen Canada’s …Their ABCL share price forecasts range from $15.00 to $34.00. On average, they predict the company's share price to reach $25.57 in the next year. This suggests a possible upside of 264.3% from the stock's current price. View analysts price targets for ABCL or view top-rated stocks among Wall Street analysts. poke delight dolar peruano cambioABCL : 5.85 (+0.17%) AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023 Business Wire - Thu Apr 6, 3:05PM CDT. AbCellera (Nasdaq: ABCL) will announce its first quarter 2023 financial results on Thursday, May 4, 2023, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same... Latest ABCL News. View. Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $25.57. Zolmax • about 5 hours ago. AbCellera Biologics Inc. …Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis.AbCellera Biologics Inc. ABCL gained 11% to ... Microbot Medical announced a $1.44 million registered direct offering of 655,569 shares of common stock at a price of $2.20 per share priced at the ... fins tropicali cuisine bradley beach menu Real time AbCellera Biologics (ABCL) stock price quote, stock graph, news & analysis. Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96.A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of AbCellera Biologics Inc (Symbol: ABCL) entered into oversold territory, hitting an RSI ...May 5, 2023 · Looking at the chart above, ABCL's low point in its 52 week range is $5.42 per share, with $14.97 as the 52 week high point — that compares with a last trade of $5.96. Latest ABCL News. View. Brokerages Set AbCellera Biologics Inc. (NASDAQ:ABCL) Target Price at $25.57. Zolmax • about 5 hours ago. AbCellera Biologics Inc. …May 19, 2023 · 70,6%. More Financials. Company. AbCellera Biologics Inc. is a technology company that searches, decodes and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. The Companyâ€™s full-stack, AI-powered antibody discovery platform searches and analyzes the database of ... May 23, 2023 · 8 brokers have issued twelve-month price targets for AbCellera Biologics' stock. Their ABCL share price forecasts range from $15.00 to $34.00. On average, they expect the company's share price to reach $25.57 in the next year. This suggests a possible upside of 337.9% from the stock's current price. AbCellera Biologics ( NASDAQ:ABCL ) First Quarter 2023 Results Key Financial Results Revenue: US$12.2m (down 96% from... Image source: The Motley Fool. AbCellera Biologics (NASDAQ: ABCL)Q1 2023 ...